| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/10/1993 | WO1993010805A1 Inhibitory immunoglobulin polypeptides to human pdgf beta receptor |
| 06/10/1993 | WO1993010802A1 Aqueous synthetic organ extracts |
| 06/10/1993 | WO1993010800A1 Method of treating non-streptococcal bacterial infections |
| 06/10/1993 | WO1993010799A1 Method of treating viral infections |
| 06/10/1993 | WO1993010798A1 Monoclonal antibody directed against g-cam and method of using it |
| 06/10/1993 | WO1993010747A2 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING |
| 06/10/1993 | WO1993010676A1 Process for producing sweetness inducer miraculin |
| 06/10/1993 | WO1993009437A3 Nuclear matrix protein fluid assay |
| 06/10/1993 | CA2125577A1 Use of protease nexin-i as an antiinflammatory |
| 06/10/1993 | CA2125298A1 Tools for the diagnosis and treatment of alzheimer's disease |
| 06/10/1993 | CA2125045A1 Nucleotide sequences coding an endopolygalacturonase inhibitor |
| 06/10/1993 | CA2124957A1 Methods for production of purified soluble type b and type a human platelet-derived growth factor receptor fragments |
| 06/10/1993 | CA2124948A1 Gamma ifn-antagonist cytokine |
| 06/10/1993 | CA2124848A1 Novel adherent and invasive mycoplasma |
| 06/10/1993 | CA2124691A1 Compositions for eliciting cytotoxic t-lymphocyte responses against viruses |
| 06/10/1993 | CA2124461A1 Human interleukin-8 analogs |
| 06/10/1993 | CA2124338A1 Region of cytoplasmic domain of the human interleukin-4 receptor, as antagonists of il-4 |
| 06/10/1993 | CA2124202A1 Hemoregulatory peptides |
| 06/10/1993 | CA2123894A1 Bispecific antibody heterodimers |
| 06/10/1993 | CA2123804A1 Recombinant viruses comprising artificial proteolytic cleavage site |
| 06/10/1993 | CA2123694A1 Peptides and antibodies for treatment of rheumatoid arthritis |
| 06/10/1993 | CA2123567A1 Production of proteins using 7b2 protein |
| 06/10/1993 | CA2122356A1 Process for screening substances with a modulating effect on a receptor-dependent cellular signal transduction pathway |
| 06/10/1993 | CA2121800A1 Multimeric forms of members of the steroid/thyroid superfamily of receptors |
| 06/10/1993 | CA2121601A1 Novel thrombin-inhibitory proteins from terrestrial leeches |
| 06/10/1993 | CA2101162A1 Dna encoding a human 5-ht1e receptor and uses thereof |
| 06/10/1993 | CA2057288A1 Trophoblast interferon |
| 06/09/1993 | EP0545730A1 Peptide with inhibitory activity towards plant pathogenic fungi |
| 06/09/1993 | EP0545554A2 Antibodies specific for RAR-gamma or a specific isoform of RAR-gamma |
| 06/09/1993 | EP0545352A1 Pharmaceutical compositions containing Lactobacillus casei peptidoglycan |
| 06/09/1993 | EP0545343A1 Ligand-binding domains of fibroblast growth factor receptors and chimeric proteins containing these domains |
| 06/09/1993 | EP0545016A1 Composition for nucleic acid complex transfer in suspension eukaryotic cells |
| 06/09/1993 | EP0544942A1 Novel tools for the diagnosis and treatment of Alzheimer disease |
| 06/09/1993 | EP0544878A1 Asialoglycoprotein-conjugated medicinal agent |
| 06/09/1993 | EP0544861A1 Immunoassay for non-a non-b hepatitis |
| 06/09/1993 | EP0544838A1 Non-a, non-b hepatitis virus antigen, diagnostic methods and vaccines |
| 06/09/1993 | EP0544832A1 Recombinant bpi proteins, uses of bpi proteins, and methods of preparing same |
| 06/09/1993 | EP0544826A1 Superior thrombomodulin analogs for pharmaceutical use |
| 06/09/1993 | EP0544815A1 Peptides from the GMP-140 lectinbindingdomain and selectin binding ligands on carbonhydrates |
| 06/09/1993 | EP0544743A1 Lymphokine 154 |
| 06/09/1993 | EP0544719A1 Cytokine production |
| 06/09/1993 | EP0544716A1 Oligonucleotide modulation of cell adhesion |
| 06/09/1993 | EP0544706A1 Histidine substituted growth hormone releasing factor analogs |
| 06/09/1993 | EP0544685A1 Mycobacterial expression vector |
| 06/09/1993 | EP0500695A4 Gnrh analogs |
| 06/09/1993 | EP0495096A4 Plant fatty acid synthases |
| 06/09/1993 | EP0368920B1 Lectines fixing beta-d-galactoside |
| 06/09/1993 | EP0134242B1 Protective peptide antigen |
| 06/08/1993 | US5218104 Bowman-Birk trypsin inhibitor isolated from Vigna unguiculata |
| 06/08/1993 | US5218101 Leader sequence inducing a post-translational modification of polypeptides in bacteria, and gene therefor |
| 06/08/1993 | US5218100 Dna encoding for the precursor protein of apc polypeptide associated with alzheimer's disease |
| 06/08/1993 | US5218099 Pure polynucleotide complimentary to or the same as specified DNA sequence |
| 06/08/1993 | US5218094 Neuronotrophic factor derived from mammalian brain tissue |
| 06/08/1993 | US5218093 Epidermal growth factor multimer and a carrier; wound healing agents |
| 06/08/1993 | US5218092 Stability |
| 06/08/1993 | US5218091 Glycolytic promoters for regulated protein expression: protease inhibitor |
| 06/08/1993 | US5218090 Epiderma growth factor glycoprotein segment containing ligand binding sites and used as a plasmid in genetic engineering |
| 06/08/1993 | US5217956 Composition and treatment with biologically active peptides and certain anions |
| 06/08/1993 | US5217954 Chelate agent added for oxidation resistance, aggregation resistance |
| 06/08/1993 | US5217953 Vasoactive intestinal peptide antagonist |
| 06/08/1993 | US5217898 Expression of the P. falciparum transmission-blocking antigen in yeast |
| 06/08/1993 | US5217896 For diagnosis and treatment of humoral hypercalcemia |
| 06/08/1993 | US5217895 Neutralization of aids; diagnosis and(or) therapy |
| 06/08/1993 | US5217891 DNA constructs containing a kluyveromyces α factor leader sequence for directing secretion of heterologous polypeptides |
| 06/08/1993 | US5217889 Randomly fragmenting DNA homologous to gene to be supressed, transferring fragments to expression vectors, introducing supressor library into living cells, isolating modified cells and obtaining supressor element from cells |
| 06/08/1993 | US5217881 Ligand reagent expressed in yeast |
| 06/08/1993 | US5217872 Diagnosing Lymes disease |
| 06/08/1993 | US5217870 Monoclonal antibodies against CDX |
| 06/08/1993 | US5217867 Measuring genetic transcription induced by steroid hormone receptors bound to DNA segments for use in screening assays |
| 06/08/1993 | US5217866 Polynucleotide assay reagent and method |
| 06/08/1993 | US5217864 Replication initiator protein complex and methods of use thereof |
| 06/08/1993 | US5217861 Detection of AIDS infections |
| 06/08/1993 | US5217717 Method of making soybean Bowman-Birk inhibitor concentrate and use of same as a human cancer preventative and therapy |
| 06/08/1993 | US5217716 Aids therapy |
| 06/08/1993 | US5217705 Method of diagnosing blood clots using fibrin-binding proteins |
| 06/08/1993 | CA1318986C Inhibition of mineral deposition by polyanionic/hydrophobic peptides and derivatives thereof |
| 06/08/1993 | CA1318985C Amino acid 1,2-diketo derivatives as renin inhibitors |
| 06/08/1993 | CA1318869C Method of removing n-terminal amino acid residues from eucaryotic polypeptide analogs and polypeptides produced thereby |
| 06/08/1993 | CA1318867C Plasmid expression vector for use in escherichia coli |
| 06/07/1993 | CA2084603A1 Construct and method for expression of heterologous genes in e. coli |
| 06/07/1993 | CA2057213A1 Trophoblast interferon |
| 06/05/1993 | CA2084331A1 Method and composition for treating viral infections |
| 06/03/1993 | DE4139639A1 Synthetic aq. organ extract free of contaminating proteins etc. - contains aminoacid(s) peptide(s), sugar alcohol, carboxylic acid and alcohol, useful e.g. in cosmetics, for wound healing and to strengthen immunity |
| 06/03/1993 | CA2083778A1 Variable region within fibroblast growth factor receptors that confers ligand specificity |
| 06/02/1993 | EP0544620A1 Macrocyclic lactams as inhibitors of atrial natriuretic factors (ANF)-degrading neutral endopeptidase (NEP) |
| 06/02/1993 | EP0544467A2 Plasmid pHKY334, an expression vector for EK-BGH and host cells transformed therewith |
| 06/02/1993 | EP0544466A1 Tri-arginine insulins |
| 06/02/1993 | EP0544293A2 Process for the preparation of biologically active NGF by genetic engineering |
| 06/02/1993 | EP0544292A2 Method of introduction of nucleic acids in cells |
| 06/02/1993 | EP0543938A1 Inhibition of influenza virus type a, ann arbor strain h2n2 by antisense oligonucleotides |
| 06/02/1993 | EP0521963A4 Crf analogs |
| 06/02/1993 | CN1072723A Tri-arginine insulins. |
| 06/01/1993 | USRE34271 Production of alpha-alpha cross-linked hemoglobins in high yield |
| 06/01/1993 | US5216143 Distinguish between Mycobacterium gordonae and other species |
| 06/01/1993 | US5216133 Thermosensitive, trypsin, chymotrypsin and mercaptam sensitive, pure protein |
| 06/01/1993 | US5216132 Soluble t-cell antigen receptor chimeric antigens |
| 06/01/1993 | US5216131 Lymphocyte homing receptors |
| 06/01/1993 | US5216129 Production of kappa-caseino-glycomacropeptide |
| 06/01/1993 | US5216128 IFN-β2/IL-6 receptor its preparation and pharmaceutical compositions containing it |
| 06/01/1993 | US5216126 Receptor polypeptides and their production and uses |